Norway· NO-ID_5C624760-45B2-4A8D-886B-942A05D3EF78
Iopidine
A apraclonidine product containing apraclonidine, registered in Norway by Essential Pharma Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Apraclonidine is registered in 14 of 19 countries.
Countries holding a registration under ATC S01EA03 (apraclonidine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Apraclonidine · ATC S01EA03
14 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Apraclonidine
- Manufacturer
- Essential Pharma Limited
- Country
- Norway (NO)
- ATC code
- S01EA03
- ATC class
- Apraclonidine
- Defined daily dose
- 0.3 ml, AT
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_5C624760-45B2-4A8D-886B-942A05D3EF78
- no_varenummer1619505NOK 165.9
- gtin5060642020182
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
77 interactions on record for apraclonidine.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Apraclonidine · interactions on record
77 records
- 4 severe
- 73 moderate
Most severe, free to view
- ProcarbazineL01XB01severe
- OzanimodL04AA38severe
- OzanimodL04AE02severe
- Methylthioninium chlorideV03AB17severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Apraclonidine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsIopidine 5 mg/ml oogdruppels, oplossingEssential Pharma Limited
- BelgiumIopidine 5 mg/mlEssential Pharma
- FinlandIopidineEssential Pharma Ltd
- IrelandIopidine 5 mg/ml Eye Drops, SolutionEssential Pharma Limited
- SwedenIopidine 5 mg/ml Ögondroppar, lösningEssential Pharma Ltd
- United KingdomApraclonidine 1% eye drops 0.25ml unit dose preservative freeEssential Pharma Ltd
- SwitzerlandIopidine
- FranceIOPIDINE 0,5 %, collyre en solutionESSENTIAL PHARMA (M) (MALTE)
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Iopidine
- Belgium · Iopidine
- Germany · Iopidine®
- Denmark · Iopidine
- Spain · Iopimax
- Finland · Iopidine
- France · Iopidine
- United Kingdom (Northern Ireland) · Apraclonidine, Apraclonidine Essential Pharma
- Greece · Iopidine
- Ireland · Iopidine
- Italy · Iopidine
- Luxembourg · Iopidine
- Malta · Iopidine
- Netherlands · Iopidine
- Portugal · Iopidine
- Sweden · Iopidine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/14bbdf1c-78df-495f-9017-0d19c1500015 GET /v1/drugs/14bbdf1c-78df-495f-9017-0d19c1500015?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Øyedråper, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Apraklonidin",
"merkevare_id": "ID_5C624760-45B2-4A8D-886B-942A05D3EF78",
"name_form_strength": "Iopidine øyedr, oppl 5 mg/ml",
"prescription_group": "C"
}See everything about apraclonidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.